Drs Oystein Fluge and Olav Mella have been given 2 million Norwegian Kroners (approx. £220,000) to help fund a larger multi-centre follow-up study to confirm their findings  that some people with ME had benefited from the immune modulator rituximab. This is not enough to fund the whole project so they are working to a draft protocol for a larger study in cooperation with the Oslo University Hospital (Aker).

When the preliminary protocol is completed, they establish collaborations with other research communities that want to take part in the study.

After that, the research protocol will be submitted to the Committee for Medical and Health Research Ethics and the Norwegian Medicines Agency.

What is Happening with the Research into ME and Rituximab?

 

 

This entry was posted in News and tagged , , . Bookmark the permalink.

Comments are closed.